A pilot study to assess feasibility of value based pricing in Cyprus through pharmacoeconomic modelling and assessment of its operational framework: sorafenib for second line renal cell cancer

BACKGROUND: The continuing increase of pharmaceutical expenditure calls for new approaches to pricing and reimbursement of pharmaceuticals. Value based pricing of pharmaceuticals is emerging as a useful tool and possess theoretical attributes to help health system cope with rising pharmaceutical exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrou, Panagiotis, Talias, Michael A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029980/
https://www.ncbi.nlm.nih.gov/pubmed/24910539
http://dx.doi.org/10.1186/1478-7547-12-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029980/
https://www.ncbi.nlm.nih.gov/pubmed/24910539
http://dx.doi.org/10.1186/1478-7547-12-12

Ejemplares similares